Clinical Trials Browser

Phase 3 × INDUSTRY × immunotoxin HA22 × Clear all

NCT01829711 2020-04-08

Moxetumomab Pasudotox for Advanced Hairy Cell Leukemia

Phase 3 Completed

80 enrolled 32 charts 1 FDA

Other hematologic neoplasm

Leukemia, Hairy Cell